Literature DB >> 15356345

Protein tyrosine phosphatase receptor-type O (PTPRO) exhibits characteristics of a candidate tumor suppressor in human lung cancer.

Tasneem Motiwala1, Huban Kutay, Kalpana Ghoshal, Shoumei Bai, Hiroyuki Seimiya, Takashi Tsuruo, Saul Suster, Carl Morrison, Samson T Jacob.   

Abstract

Previous study in our laboratory demonstrated suppression of the gene for protein tyrosine phosphatase receptor-type O (PTPRO) in primary and established rat hepatomas. The present study showed methylation-mediated silencing of this gene in primary human lung tumors and in several human lung cancer cell lines, one of the characteristics of many tumor-suppressor genes. The reduced expression of PTPRO in the primary lung tumors correlated with the methylation status of its CpG island. Demethylation of the gene by deoxy-5-azacytidine treatment led to its reactivation in a lung cancer line (A549). Overexpression of PTPRO in A549 cells inhibited anchorage-independent growth, delayed reentry of the cells into the cell cycle after release from cell-cycle arrest, and increased susceptibility of the cells to apoptosis. These data have demonstrated the growth-suppressor characteristics of PTPRO that are unique to a classical tumor suppressor.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15356345      PMCID: PMC518843          DOI: 10.1073/pnas.0405451101

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  35 in total

1.  Identification of a novel thioredoxin-related transmembrane protein.

Authors:  Y Matsuo; N Akiyama; H Nakamura; J Yodoi; M Noda; S Kizaka-Kondoh
Journal:  J Biol Chem       Date:  2001-01-04       Impact factor: 5.157

Review 2.  Protein tyrosine phosphatases: prospects for therapeutics.

Authors:  Z Y Zhang
Journal:  Curr Opin Chem Biol       Date:  2001-08       Impact factor: 8.822

3.  Isolation and characterization of murine orthologue of PTP-BK.

Authors:  T Tomemori; N Seki; Y Suzuki; T Shimizu; H Nagata; A Konno; T Shirasawa
Journal:  Biochem Biophys Res Commun       Date:  2000-10-05       Impact factor: 3.575

4.  Silencing of metallothionein-I gene in mouse lymphosarcoma cells by methylation.

Authors:  S Majumder; K Ghoshal; Z Li; Y Bo; S T Jacob
Journal:  Oncogene       Date:  1999-11-04       Impact factor: 9.867

5.  Protein tyrosine phosphatase phi regulates paxillin tyrosine phosphorylation and mediates colony-stimulating factor 1-induced morphological changes in macrophages.

Authors:  F J Pixley; P S Lee; J S Condeelis; E R Stanley
Journal:  Mol Cell Biol       Date:  2001-03       Impact factor: 4.272

Review 6.  Combinatorial control of the specificity of protein tyrosine phosphatases.

Authors:  N K Tonks; B G Neel
Journal:  Curr Opin Cell Biol       Date:  2001-04       Impact factor: 8.382

7.  Suppression of metallothionein gene expression in a rat hepatoma because of promoter-specific DNA methylation.

Authors:  K Ghoshal; S Majumder; Z Li; X Dong; S T Jacob
Journal:  J Biol Chem       Date:  2000-01-07       Impact factor: 5.157

8.  PTPROt: an alternatively spliced and developmentally regulated B-lymphoid phosphatase that promotes G0/G1 arrest.

Authors:  R C Aguiar; Y Yakushijin; S Kharbanda; S Tiwari; G J Freeman; M A Shipp
Journal:  Blood       Date:  1999-10-01       Impact factor: 22.113

9.  Hypermethylation of metallothionein-I promoter and suppression of its induction in cell lines overexpressing the large subunit of Ku protein.

Authors:  S Majumder; K Ghoshal; Z Li; S T Jacob
Journal:  J Biol Chem       Date:  1999-10-01       Impact factor: 5.157

10.  Molecular cloning, expression, and distribution of glomerular epithelial protein 1 in developing mouse kidney.

Authors:  R Wang; P L St John; M Kretzler; R C Wiggins; D R Abrahamson
Journal:  Kidney Int       Date:  2000-05       Impact factor: 10.612

View more
  50 in total

Review 1.  Molecular Pathways: Targeting Protein Tyrosine Phosphatases in Cancer.

Authors:  Lakshmi Reddy Bollu; Abhijit Mazumdar; Michelle I Savage; Powel H Brown
Journal:  Clin Cancer Res       Date:  2017-01-13       Impact factor: 12.531

2.  AP-1 elements and TCL1 protein regulate expression of the gene encoding protein tyrosine phosphatase PTPROt in leukemia.

Authors:  Tasneem Motiwala; Nicola Zanesi; Jharna Datta; Satavisha Roy; Huban Kutay; Allyn M Checovich; Mohamed Kaou; Yiming Zhong; Amy J Johnson; David M Lucas; Nyla A Heerema; John Hagan; Xiaokui Mo; David Jarjoura; John C Byrd; Carlo M Croce; Samson T Jacob
Journal:  Blood       Date:  2011-10-14       Impact factor: 22.113

Review 3.  Role of protein tyrosine phosphatases in cancer.

Authors:  Tasneem Motiwala; Samson T Jacob
Journal:  Prog Nucleic Acid Res Mol Biol       Date:  2006

4.  Methylation mediated silencing of MicroRNA-1 gene and its role in hepatocellular carcinogenesis.

Authors:  Jharna Datta; Huban Kutay; Mohd W Nasser; Gerard J Nuovo; Bo Wang; Sarmila Majumder; Chang-Gong Liu; Stefano Volinia; Carlo M Croce; Thomas D Schmittgen; Kalpana Ghoshal; Samson T Jacob
Journal:  Cancer Res       Date:  2008-07-01       Impact factor: 12.701

5.  Integrated genomic analysis of relapsed childhood acute lymphoblastic leukemia reveals therapeutic strategies.

Authors:  Laura E Hogan; Julia A Meyer; Jun Yang; Jinhua Wang; Nicholas Wong; Wenjian Yang; Gregory Condos; Stephen P Hunger; Elizabeth Raetz; Richard Saffery; Mary V Relling; Deepa Bhojwani; Debra J Morrison; William L Carroll
Journal:  Blood       Date:  2011-09-14       Impact factor: 22.113

6.  GLEPP1/protein-tyrosine phosphatase phi inhibitors block chemotaxis in vitro and in vivo and improve murine ulcerative colitis.

Authors:  Rosanna Pescini Gobert; Monique van den Eijnden; Cedric Szyndralewiez; Catherine Jorand-Lebrun; Dominique Swinnen; Linfeng Chen; Corine Gillieron; Fiona Pixley; Pierre Juillard; Patrick Gerber; Caroline Johnson-Léger; Serge Halazy; Montserrat Camps; Agnes Bombrun; Margaret Shipp; Pierre-Alain Vitte; Vittoria Ardissone; Chiara Ferrandi; Dominique Perrin; Christian Rommel; Rob Hooft van Huijsduijnen
Journal:  J Biol Chem       Date:  2009-02-20       Impact factor: 5.157

7.  Plasma protein profiling in a stage defined pancreatic cancer cohort - Implications for early diagnosis.

Authors:  Anna Sandström Gerdtsson; Christer Wingren; Helena Persson; Payam Delfani; Malin Nordström; He Ren; Xin Wen; Ulrika Ringdahl; Carl A K Borrebaeck; Jihui Hao
Journal:  Mol Oncol       Date:  2016-07-12       Impact factor: 6.603

8.  Down-regulation of micro-RNA-1 (miR-1) in lung cancer. Suppression of tumorigenic property of lung cancer cells and their sensitization to doxorubicin-induced apoptosis by miR-1.

Authors:  Mohd W Nasser; Jharna Datta; Gerard Nuovo; Huban Kutay; Tasneem Motiwala; Sarmila Majumder; Bo Wang; Saul Suster; Samson T Jacob; Kalpana Ghoshal
Journal:  J Biol Chem       Date:  2008-09-25       Impact factor: 5.157

9.  PTPROt inactivates the oncogenic fusion protein BCR/ABL and suppresses transformation of K562 cells.

Authors:  Tasneem Motiwala; Sarmila Majumder; Kalpana Ghoshal; Huban Kutay; Jharna Datta; Satavisha Roy; David M Lucas; Samson T Jacob
Journal:  J Biol Chem       Date:  2008-11-07       Impact factor: 5.157

10.  Methylation of the PTPRO gene in human hepatocellular carcinoma and identification of VCP as its substrate.

Authors:  Shu-hao Hsu; Tasneem Motiwala; Satavisha Roy; Rainer Claus; Mufaddal Mustafa; Christoph Plass; Michael A Freitas; Kalpana Ghoshal; Samson T Jacob
Journal:  J Cell Biochem       Date:  2013-08       Impact factor: 4.429

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.